Hematology/Oncology

Top Story

Interaction between prostate cancer, comorbidities increases VTE risk

August 4, 2015

High levels of comorbidities considerably increased venous thromboembolism risk among patients with prostate cancer, according to results of a national cohort study.

The clinical interaction between prostate cancer and those comorbidities accounted for nearly one-third of VTEs among that patient population, results showed. Consequently, the ability to reduce VTEs associated with comorbidities may help improve the prognosis of patients with prostate cancer, researchers wrote.

FDA News

FDA grants orphan drug designation to veltuzumab for ITP

August 4, 2015
The FDA granted orphan drug designation to veltuzumab — a humanized anti-CD20 antibody — for the treatment of patients with immune thrombocytopenia…
In the Journals

Urine biomarkers accurately identify early-stage pancreatic cancer

August 4, 2015
Researchers have developed a three-biomarker panel that can detect early-stage pancreatic ductal adenocarcinoma through urine analysis, which could lead to a noninvasive…
Rita F. Redberg, MD, MSc In the Journals

Surrogate endpoints may not predict OS in oncology clinical trials

August 4, 2015
A majority of trial-level validation studies of surrogate endpoints demonstrated little correlation with survival rates, according to a systematic review of trial-level…
Hatem A. Azim, Jr., MD In the Journals

Assisted reproduction feasible for women with breast cancer history

August 4, 2015
Women with a history of breast cancer can utilize assisted reproductive technology to become pregnant without any detriment to their cancer outcome, according to study…
More News Headlines »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Meeting News Coverage Video
VIDEO: 'Care paths' may help manage rising cancer costs

VIDEO: 'Care paths' may help manage rising cancer costs

June 19, 2015
CHICAGO — Brian Bolwell, MD, chairman of Taussig Cancer Institute at Cleveland Clinic, discusses an abstract on…
More »
CME
Hematology Oncology Case Consults

The Patient with Multiple Myeloma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with multiple myeloma.
More »
morganatic-roan
morganatic-roan